Trade Summary

3 days ago, RA CAPITAL MANAGEMENT, L.P., serving as 10% owner Owner at Hemab Therapeutics Holdings, Inc. (COAG), purchased 67,669 shares at $24.97 per share, for a total transaction value of $1,689,818.48. Following this transaction, RA CAPITAL MANAGEMENT, L.P. now holds 6,444,637 shares of COAG.

This purchase represents a 1.06% increase in RA CAPITAL MANAGEMENT, L.P.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 17, 2026 at 6:24 PM ET, 2 days after the trade was made.

Hemab Therapeutics Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.